Health Workforce Innovation Act

Federal Affairs lobbies for Appropriations for health centers and related primary care workforce programs. This includes the House Appropriations Committee's Fiscal Year 2025 Department of Labor, Health and Human Services, and Education, and related agencies appropriations bills, the Lower Costs More Transparency Act (H.R. 5378); the Bipartisan Primary Care and Health Workforce Act (S.2840); the Preventative Health Savings Act (H.R. 766) (S. 114); the Health Care Workforce Innovation Act (H.R. 7307); the Health Workforce Innovation Act (S. 4957); the Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025; and the American Relief Act, 2025.

Client expense: $152,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE

Issues regarding nursing and allied health care shortages, pipeline, and career perception. Issues involving nursing faculty shortage and use of artificial intelligence in education. S. 2840, Bipartisan Health Care and Health Workforce Act, as it relates to workforce shortages. Monitored H.R. 2411 / S. 1150, National Nursing Workforce Center Act. Monitored H.R. 4328, National Nursing Shortage Task Force Act. H.R. 6585, Bipartisan Workforce Pell Act. S. 2304, Allied Health Opportunity Act. H.R. 6122 / S. 2853, Train More Nurses Act. Issues involving nursing licensure and examinations. H.R. 7002 / S. 2815, Nurse Faculty Shortage Reduction Act. S. 4957, Health Workforce Innovation Act. S. 1627, PRECEPT Nurses Act.

Client expense: Not reported · Firm income: $60,000

340B Drug Pricing Program - Continued to urge action to ensure covered entities have access to 340B discounted prices through contract pharmacies. Highlighted critical importance of the 340B program for hospitals. Buffer inventory - Engagements with CMS on reimbursement for hospitals that stockpile buffer supplies of essential medicines. Children's Hospital Graduate Medical Education (CHGME) - Continued to urge Congress to reauthorize CHGME program through the Childrens Hospital GME Support Reauthorization Act of 2023 (H.R. 3887). Offered support for providing $738 million in funding the CHGME program. Drug shortages -Supported elements to increase transparency in prescription drug supply chain and increase reimbursement for generic prescription drugs; issues related to compounding; issues related to buffer inventory. Continued supporting passage of The Drug Shortage Prevention Act (H.R. 3008) and The Drug Origin Transparency Act (H.R. 3810). Provided feedback on the Senate Finance Committee discussion draft on the Drug Shortage Prevention and Mitigation Act (No Bill Number) legislation. Healthcare Workforce - Monitored development of the Bipartisan Primary Care and Health Workforce Act (S.2840) and the Safety from Violence for Healthcare Employees (SAVE) Act (H.R. 2584/S. 2768). Hospital Group Purchasing - Advocated to highlight the value that hospital group purchasing organizations provide to hospitals and suppliers. Provided education on how GPOs work in the healthcare supply chain and the role they play in delivering value to healthcare providers, as well as key differences between traditional GPOs and PBMs. Interchangeability Status - Responded to the Food and Drug Administration (FDA) draft guidance on Considerations for Demonstrating Interchangeability with a Reference Product: Update. Urged FDA to promptly finalize the Draft Guidance. Medical Device Sterilization - Conducted education and outreach on the potential negative impact on the healthcare supply chain of pending regulations limiting the use of Ethylene Oxide as a medical device sterilant. Mental and Behavioral Health - Highlighted the need for legislation to address significant challenges to mental and behavioral health treatment, including increased demand for services, limited access to treatment, and clinician shortages. Payer-mandated White Bagging - Urged support for policy updates related to payer-mandated white bagging for medications. Social Determinants of Health - Encouraged Congress and agencies to ensure tools like the Vizient Vulnerability Index are being utilized to understand and identify social drivers of health at the neighborhood level. Telehealth - Continued supporting passage of the CONNECT for Health Act (S. 2016/H.R. 4189). Continued to advocate for the adoption of permanent telehealth policies to extend flexibilities beyond the current 2024 expiration date. Telemedicine prescribing - Encouraged Congress to pass a two-year extension of Drug Enforcement Administration (DEA) prescribing flexibilities without requiring an in-person medical evaluation. Workforce - Encouraged passage of The Health Workforce Innovation Act (S.4957).

Issues regarding nursing and allied health care shortages, pipeline, and career perception. Issues involving nursing faculty shortage and use of artificial intelligence in education. S. 2840, Bipartisan Health Care and Health Workforce Act, as it relates to workforce shortages. Monitored H.R. 2411 / S. 1150, National Nursing Workforce Center Act. Monitored H.R. 4328, National Nursing Shortage Task Force Act. H.R. 6585, Bipartisan Workforce Pell Act. S. 2304, Allied Health Opportunity Act. H.R. 6122 / S. 2853, Train More Nurses Act. Issues involving nursing licensure and examinations. H.R. 7002 / S. 2815, Nurse Faculty Shortage Reduction Act. S. 4957, Health Workforce Innovation Act. S. 1627, PRECEPT Nurses Act.

Client expense: Not reported · Firm income: $60,000

Federal Affairs lobbies for Appropriations for health centers and related primary care workforce programs. This includes the House Appropriations Committee's Fiscal Year 2025 Department of Labor, Health and Human Services, and Education, and related agencies appropriations bills, the Lower Costs More Transparency Act (H.R. 5378); the Bipartisan Primary Care and Health Workforce Act (S.2840); the Preventative Health Savings Act (H.R. 766) (S. 114); the Health Care Workforce Innovation Act (H.R. 7307) and the Health Workforce Innovation Act (S. 4957)

Client expense: $152,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE

Federal Affairs lobbies for Appropriations for health centers and related primary care workforce programs. This includes the House Appropriations Committee's Fiscal Year 2025 Department of Labor, Health and Human Services, and Education, and related agencies appropriations bills, the Lower Costs More Transparency Act (H.R. 5378); the Bipartisan Primary Care and Health Workforce Act (S.2840); the Preventative Health Savings Act (H.R. 766) (S. 114); the Health Care Workforce Innovation Act (H.R. 7307) and the Health Workforce Innovation Act (S. 4957)

Client expense: $145,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE

Authorization and implementation of the Higher Education Act of 1965, as amended; authorization of the Public Health Service Act, as amended, including S 4957.

Client expense: Not reported · Firm income: $30,000

Government targets: Education, Dept of, HOUSE OF REPRESENTATIVES, SENATE